Ardelyx, Inc. (ARDX): Gross Profit
$367.78M
Year ended 2025-12-31
$425.49M
Trailing 12 months to 2026-06-30
+97.1%
3-year compound annual growth
+31.4%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $367.78M | +29.9% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $283.06M | +165.4% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $106.66M | +122.0% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $48.04M | +428.1% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $9.10M | n/a | 2024-02-22, From 2021-01-01 |
| No annual figure between 2019-12-31 and 2021-12-31. | |||
| 2019-12-31 | $4.68M | +118.6% | 2020-03-06, From 2019-01-01 |
| 2018-12-31 | $2.14M | -93.6% | 2020-03-06, From 2018-01-01 |
| 2017-12-31 | $33.60M | n/a | 2020-03-06, From 2017-01-01 |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | $24.03M | n/a | 2018-03-14, From 2015-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $367.78M | +29.9% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $307.67M | +3.9% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $261.98M | +18.7% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $335.38M | +127.5% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $266.66M | +6.5% |
| MannKind Corp (MNKD) | 2025-12-31 | $322.17M | +20.2% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $347.72M | +7.1% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $275.75M | +584.5% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $212.16M | -24.6% |
Compare ARDX, INVA, SVA, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗